Neurocrine Biosciences (NBIX) Change in Taxes (2024 - 2026)

Neurocrine Biosciences has reported Change in Taxes for 3 years, with the latest figure at $119.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Taxes rose 677.92% year-over-year to $119.8 million; the trailing twelve-month figure through Mar 2026 stood at $225.8 million (changed N/A YoY), and the FY2025 full-year result was -$18.8 million, down 137.38% from the prior year.
• Change in Taxes for Q1 2026 stood at $119.8 million, up from $35.5 million in the prior quarter.
• The five-year high for Change in Taxes was $119.8 million in Q1 2026, with the low at $15.4 million in Q1 2025.
• Historically, Change in Taxes has averaged $56.4 million across 3 years, with a median of $45.3 million in 2024.
• Annual changes were most pronounced in 2025 — Change in Taxes plunged 35.57% — and 2026, when it surged 677.92%.
• Neurocrine Biosciences' Change in Taxes stood at $55.1 million in 2024, then sank by 35.57% to $35.5 million in 2025, then surged by 237.46% to $119.8 million in 2026.
• The last three Change in Taxes figures came in at $119.8 million (Q1 2026), $35.5 million (Q4 2025), and $15.4 million (Q1 2025), per Business Quant data.